(Q36755011)

16 August 2017

In vitro susceptibility of Brucella melitensis to antibiotics (English)

1 reference

16 August 2017

0 references

Brucella melitensis

1 reference

Rubinstein E

1 reference

16 August 2017

Lang R

1 reference

16 August 2017

Shasha B

1 reference

16 August 2017

Hagar B

1 reference

16 August 2017

Diamanstein L

1 reference

16 August 2017

Joseph G

1 reference

16 August 2017

Anderson M

1 reference

16 August 2017

Harrison K

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 September 1991

1 reference

Antimicrobial Agents and Chemotherapy

16 August 2017

1 reference

16 August 2017

1 reference

16 August 2017

1 reference

16 August 2017

1925-1927

1 reference

In vitro activity of N-formimidoyl thienamycin against 98 clinical isolates of Brucella melitensis compared with those of cefoxitin, rifampin, tetracycline, and co-trimoxazole

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245295

In vitro susceptibility of Brucella to various antibiotics

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245295

Relevance of in vitro antimicrobial susceptibility of Brucella melitensis to relapse rate in human brucellosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245295

The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245295

The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245295

Comparative in vitro activities of ofloxacin, difloxacin, ciprofloxacin, and other selected antimicrobial agents against Brucella melitensis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245295

Multicenter prospective study of treatment of Brucella melitensis brucellosis with doxycycline for 6 weeks plus streptomycin for 2 weeks

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245295

Sensitivity of Brucella spp to tetracycline and its analogues

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245295

Rifampin in the treatment of experimental brucellosis in mice and guinea pigs

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245295

Comparative trial of co-trimoxazole versus tetracycline-streptomycin in treating human brucellosis

29 September 2017

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/1952869

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

In-vitro activity of ciprofloxacin, ceftriaxone and five other antimicrobial agents against 95 strains of Brucella melitensis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/1952869

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Susceptibility of Brucella melitensis to fluoroquinolones

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/1952869

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.35.9.1925

1 reference

16 August 2017

1 reference

16 August 2017

PubMed publication ID

1952869

1 reference